TNB Tech Minute: AI Startup Mercor Valued at $10 Billion
WSJ Tech News Briefing
00:00
Novartis Acquires Avidity for Neuromuscular Focus
Zoe Kolkin details Novartis's $12 billion purchase of Avidity Biosciences to bolster treatments for muscular dystrophy.
Play episode from 01:10
Transcript
